Cypher
Sponsors
Cordis US Corp., Seung-Jung Park, Seoul National University Hospital
Conditions
Coronary Artery DiseaseIn-stent Restenosis
Phase 2
Phase 4
Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions
CompletedNCT00418067
Start: 2006-10-31End: 2009-01-31Updated: 2012-08-21
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
CompletedNCT00485030
Start: 2007-03-31End: 2011-10-31Updated: 2012-08-08
Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus
CompletedNCT00997763
Start: 2008-07-31End: 2015-08-31Updated: 2016-12-13
Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the AsIAN Population
CompletedNCT00997711
Start: 2009-04-30End: 2012-06-30Updated: 2015-11-17
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)
CompletedNCT01078038
Start: 2008-06-30End: 2010-08-31Updated: 2012-08-08
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV)
CompletedNCT01186094
Start: 2009-05-31End: 2011-06-30Updated: 2012-08-08